Dates : 17 – 22 August 2025 Location : Vienna, Austria Several representatives from our laboratory will have the pleasure of participating in the 19th International Congress of Immunology, organized…
Paris, France, June 10th 2025 – Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases, today announced a poster presentation at…
Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases, today announced a poster presentation at the upcoming 2025 American Society of…
Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases, will present two posters at the American Association for Cancer Research Annual…
Dates : 30 May – 3 June 2025 Location : Chicago, Illinois Several representatives from our laboratory will have the pleasure of participating in the ASCO 2025 congress. Learn more…
Dates : 11 June – 14 June 2025 Location : Barcelona, Spain Several representatives from our laboratory will have the pleasure of participating in the EULAR 2025 congress. Learn more…
Dates : 12 May – 14 May 2025 Location : Bruges, Belgium Some representatives from our laboratory will have the pleasure of participating in the Bio€quity Europe 2025. Learn more…
Dates : April 25 – April 30 2025 Location : Chicago, Illinois Several representatives from our laboratory will have the pleasure of participating in the AACR Annual Meeting 2025. Learn…